BP000160-CYT-163: Recombinant Rat Interleukin-7 (IL-7) Protein
Source: E. coli-derived.
Fully biologically active when compared to standard. The ED50 was determined by the dose-dependent stimulation of the proliferation of murine 2E8 cells is less than 0.2 ug/ml, corresponding to a specific activity of 5,000,000 IU/mg.
Purity: > 98.0% by SDS-PAGE.BP000160-CYT-254: Recombinant Human Interleukin-7 (IL-7) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine IXN/2B cells is < 0.5 ug/ml, corresponding to a Specific Activity of 2 MIU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000159-CYT-213: Recombinant Human Interleukin-6 (IL-6) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine 7TD1 cells is less than 0.1 ug/ml, corresponding to the specific activity of 1.0 x 10,000,000 Units per mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000159-CYT-274: Recombinant Human Interleukin-6 (IL-6) Protein, CHO
Source: Chinese Hamster Ovarian Cells-derived.
The activity was measured in a cell prolifiration assay using B9 cells. The ED50 for this effect is 0.008-0.02 ug/ml corresponding to a Specific Activity of 50-125 MIU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000159-CYT-350: Recombinant Mouse Interleukin-6 (IL-6) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of IL-6-dependent murine 7TD1 cells is < 0.02 ug/ml, corresponding to a specific activity of > 50,000,000 units/mg.
Purity: > 96% by SDS-PAGE and RP-HPLC.BP000159-CYT-388: Recombinant Rat Interleukin-6 (IL-6) Protein
Source: E. coli-derived.
The ED50 = 0.03-0.1 ug/ml corresponding to a specific activity of 10-34 MIU/mg. The biological activity is determined by measuring the dose-dependant proliferation of IL-6 dapendent B9 cells. A concentration range of 0.1 to 10.0 ug/ml is effective for most in vitro applications.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000158-CYT-212: Recombinant Human IL-5
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of TF-1 cells was found to be < 0.15 ug/ml, corresponding to a Specific Activity of 6.7 MIU/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000158-CYT-387: Recombinant Rat IL-5
Source: E. coli-derived.
The ED50 range=0.3-1.0 ug/ml as determined by the dose-dependant stimulation of the proliferation of BCL-1 cells.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000158-CYT-689: Recombinant Mouse IL-5
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of TF-1 cells was found to be 1.7 ug/ml, corresponding to a specific activity of 588,235.3 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000157-CYT-271: Recombinant Human Interleukin-4 (IL-4) Protein, CHO
Source: Chinese Hamster Ovarian Cells-derived.
Measured in a cell proliferation assay using TF-1 cells. The ED50 for this effect is 0.05-0.2 ug/ml corresponding to a Specific Activity of 5-20 MIU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.